BETH LEDVORA: Open Payments
NPI 1104993161 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 93 payments from 18 companies in 2025. Trend: 2023 $2,076 · 2024 $2,637 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $258 |
| Axsome Therapeutics, Inc. | 10 | $210 |
| ABBVIE INC. | 8 | $181 |
| Otsuka America Pharmaceutical, Inc. | 7 | $167 |
| Neurocrine BioSciences, Inc. | 9 | $167 |
| Vanda Pharmaceuticals Inc. | 8 | $166 |
| Lundbeck LLC | 7 | $143 |
| Corium, LLC | 6 | $122 |
| Alkermes, Inc. | 6 | $106 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
Products named: REXULTI, CAPLYTA, Auvelity, VRAYLAR, INGREZZA, FANAPT, Azstarys, LYBALVI.
Industry payments across IL — which companies pay providers there.
